Human Monoclonal Anti‐D with Reactivity against Category D<sup>VI</sup> Cells Used in Blood Grouping and Determination of the Incidence of the Category D<sup>VI</sup> Phenotype in the D<sup>U</sup> Population
K A Leader(NHS Blood and Transplant), B. A. Bradley(Southmead Hospital), J. T. Kirkwood(Bristol Institute for Transfusion Sciences), Anthony H. Merry, Belinda M. Kumpel(NHS Blood and Transplant), G. D. Poole(Bristol Institute for Transfusion Sciences)
Cited by 33
Related Papers
Mechanism of anti-D-mediated immune suppression – a paradox awaiting resolution?
|Trends in Immunology|2001|103
Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti‐D immunoglobulin: more questions than answers
|Vox Sanguinis|2007|97
Human monoclonal anti‐D antibodies. I. THEIR PRODUCTION, SEROLOGY, QUANTITATION AND POTENTIAL USE AS BLOOD GROUPING REAGENTS
|British Journal of Haematology|1989|93